Christine Silverstein
Direktor/Vorstandsmitglied bei ABEONA THERAPEUTICS INC.
Vermögen: 388 339 $ am 31.05.2024
Profil
Christine Berni Silverstein is currently an Independent Director at Abeona Therapeutics, Inc. and Marinus Pharmaceuticals, Inc. She is also a Member of the National Investor Relations Institute, Women in Bio, Inc., and Project 1972, Inc. In addition, she is the Chief Financial Officer at Artios Pharma Ltd.
starting in 2024.
Previously, she worked as a Managing Director at SCO Financial Group LLC.
She was also the Director-Investor Relations at Relmada Therapeutics, Inc. from 2014 to 2016.
From 2021 to 2024, she served as the Chief Financial Officer at Excision BioTherapeutics, Inc. Prior to that, she held the position of Chief Financial Officer at Emendo Biotherapeutics, Inc. from 2020 to 2021.
Ms. Silverstein obtained her undergraduate degree from the Peter J.
Tobin College of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.09.2023 | 87 884 ( 0,21% ) | 384 932 $ | 31.05.2024 | |
| 01.04.2024 | 2 399 ( 0,00% ) | 3 407 $ | 31.05.2024 |
Aktive Positionen von Christine Silverstein
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 11.03.2020 |
| MARINUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 26.01.2023 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Women in Bio, Inc.
 Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Corporate Officer/Principal | - |
Project 1972, Inc.
 Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Project 1972, Inc. engages in the provision of private networking platform for women. Its membership services include core group, salon series, connection, and clubhouses access. The company was founded by Lindsay Kaplan and Carolyn Childers in 2017 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Finanzdirektor/CFO | 01.02.2024 |
Ehemalige bekannte Positionen von Christine Silverstein
| Unternehmen | Position | Ende |
|---|---|---|
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Finanzdirektor/CFO | 01.01.2024 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Finanzdirektor/CFO | 01.01.2021 |
| RELMADA THERAPEUTICS, INC. | Investor Relations Kontakt | 01.01.2016 |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Christine Silverstein
| Peter J. Tobin College of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance SCO Financial Group LLC operates a full service merchant bank, which is engaged in providing services to life sciences companies. It also offers fund management, investment banking and corporate partnering and licensing services to healthcare companies. The company was founded in 1997 and is headquartered in New York, NY. | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Commercial Services |
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Commercial Services |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Project 1972, Inc. engages in the provision of private networking platform for women. Its membership services include core group, salon series, connection, and clubhouses access. The company was founded by Lindsay Kaplan and Carolyn Childers in 2017 and is headquartered in New York, NY. | Commercial Services |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
